• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡格列酮通过抑制 M1 极化缓解高脂饮食引起的泪腺损伤。

Pioglitazone alleviates lacrimal gland impairments induced by high-fat diet by suppressing M1 polarization.

机构信息

Department of Ophthalmology, Changzheng Hospital of Naval Medicine University, Shanghai, China.

Department of Ophthalmology, Changzheng Hospital of Naval Medicine University, Shanghai, China.

出版信息

J Lipid Res. 2024 Sep;65(9):100606. doi: 10.1016/j.jlr.2024.100606. Epub 2024 Jul 26.

DOI:10.1016/j.jlr.2024.100606
PMID:39067519
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11386124/
Abstract

A high-fat diet (HFD) contributes to the pathogenesis of various inflammatory and metabolic diseases. Previous research confirms that under HFD conditions, the extraorbital lacrimal glands (ELGs) can be impaired, with significant infiltration of pro-inflammatory macrophages (Mps). However, the relationship between HFD and Mps polarization in the ELGs remains unexplored. We first identified and validated the differential expression of PPAR-γ in murine ELGs fed ND and HFD through RNA sequencing. Tear secretion was measured using the Schirmer test. Lipid droplet deposition within the ELGs was observed through Oil Red O staining and transmission electron microscopy. Mps phenotypes were determined through quantitative RT-PCR, immunofluorescence, and flow cytometric analysis. An in vitro high-fat culture system for Mps was established using palmitic acid (PA), with supernatants collected for co-culture with lacrimal gland acinar cells. Gene expression was determined through ELISA, immunofluorescence, immunohistochemistry, quantitative RT-PCR, and Western blot analysis. Pioglitazone reduced M1-predominant infiltration induced by HFD by increasing PPAR-γ levels in ELGs, thereby alleviating lipid deposition and enhancing tear secretion. In vitro tests indicated that PPAR-γ agonist shifted Mps from M1-predominant to M2-predominant phenotype in PA-induced Mps, reducing lipid synthesis in LGACs and promoting lipid catabolism, thus alleviating lipid metabolic disorders within ELGs. Conversely, the PPAR-γ antagonist induced opposite effects. In summary, the lacrimal gland is highly sensitive to high-fat and lipid metabolic disorders. Downregulation of PPAR-γ expression in ELGs induces Mps polarization toward predominantly M1 phenotype, leading to lipid metabolic disorder and inflammatory responses via the NF-κb/ERK/JNK/P38 pathway.

摘要

高脂肪饮食(HFD)是多种炎症和代谢性疾病发病机制的一个重要因素。先前的研究证实,在 HFD 条件下,眼外泪腺(ELG)会受到损伤,大量促炎巨噬细胞(Mps)浸润。然而,HFD 与 ELG 中 Mps 极化的关系尚未得到探索。我们首先通过 RNA 测序鉴定并验证了在 ND 和 HFD 喂养的小鼠 ELG 中 PPAR-γ 的差异表达。通过 Schirmer 测试测量泪液分泌。通过油红 O 染色和透射电子显微镜观察 ELG 内的脂滴沉积。通过定量 RT-PCR、免疫荧光和流式细胞术分析确定 Mps 表型。使用棕榈酸(PA)建立了 Mps 的体外高脂肪培养系统,并收集上清液与泪腺腺泡细胞共培养。通过 ELISA、免疫荧光、免疫组化、定量 RT-PCR 和 Western blot 分析确定基因表达。吡格列酮通过增加 ELG 中 PPAR-γ 的水平,减少由 HFD 引起的 M1 优势浸润,从而减轻脂滴沉积并增强泪液分泌,从而减轻 M1 优势浸润。体外试验表明,PPAR-γ 激动剂使 Mps 在 PA 诱导的 Mps 中从 M1 优势表型转变为 M2 优势表型,减少 LGAC 中的脂质合成并促进脂质代谢,从而减轻 ELG 中的脂质代谢紊乱。相反,PPAR-γ 拮抗剂则诱导相反的效果。总之,泪腺对高脂肪和脂质代谢紊乱非常敏感。ELG 中 PPAR-γ 表达的下调诱导 Mps 向主要为 M1 表型极化,通过 NF-κb/ERK/JNK/P38 途径导致脂质代谢紊乱和炎症反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/a780ad30b5f2/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/4fa47247cc28/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/914359ad9827/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/f4340efcbeec/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/ba71f271dd31/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/b0323fe3cf87/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/326f7b20db49/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/703f95effc9c/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/9d32c03528ae/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/998e50af9711/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/eb89214aa81e/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/e5de0d895155/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/a780ad30b5f2/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/4fa47247cc28/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/914359ad9827/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/f4340efcbeec/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/ba71f271dd31/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/b0323fe3cf87/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/326f7b20db49/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/703f95effc9c/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/9d32c03528ae/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/998e50af9711/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/eb89214aa81e/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/e5de0d895155/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/11386124/a780ad30b5f2/figs1.jpg

相似文献

1
Pioglitazone alleviates lacrimal gland impairments induced by high-fat diet by suppressing M1 polarization.吡格列酮通过抑制 M1 极化缓解高脂饮食引起的泪腺损伤。
J Lipid Res. 2024 Sep;65(9):100606. doi: 10.1016/j.jlr.2024.100606. Epub 2024 Jul 26.
2
Pioglitazone decreased renal calcium oxalate crystal formation by suppressing M1 macrophage polarization via the PPAR-γ-miR-23 axis.吡格列酮通过PPAR-γ-miR-23轴抑制M1巨噬细胞极化,从而减少肾草酸钙晶体形成。
Am J Physiol Renal Physiol. 2019 Jul 1;317(1):F137-F151. doi: 10.1152/ajprenal.00047.2019. Epub 2019 May 15.
3
Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.通过调节过氧化物酶体增殖物激活受体-γ活性来调节脂质诱导的巨噬细胞极化,通过 Toll 样受体 4/NF-κB 信号通路影响肝脏脂质代谢。
J Gastroenterol Hepatol. 2020 Nov;35(11):1998-2008. doi: 10.1111/jgh.15025. Epub 2020 Mar 18.
4
High-Fat Nutritional Challenge Reshapes Circadian Signatures in Murine Extraorbital Lacrimal Glands.高脂肪营养挑战重塑了小鼠眼外泪腺的昼夜节律特征。
Invest Ophthalmol Vis Sci. 2022 May 2;63(5):23. doi: 10.1167/iovs.63.5.23.
5
Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease.过氧化物酶体增殖物激活受体-γ 活性对非酒精性脂肪性肝病发展中枯否细胞 M1/M2 极化的影响。
Sci Rep. 2017 Mar 16;7:44612. doi: 10.1038/srep44612.
6
MiR-130b promotes obesity associated adipose tissue inflammation and insulin resistance in diabetes mice through alleviating M2 macrophage polarization via repression of PPAR-γ.微小RNA-130b通过抑制过氧化物酶体增殖物激活受体γ来减轻M2巨噬细胞极化,从而促进糖尿病小鼠肥胖相关的脂肪组织炎症和胰岛素抵抗。
Immunol Lett. 2016 Dec;180:1-8. doi: 10.1016/j.imlet.2016.10.004. Epub 2016 Oct 13.
7
High-Fat Diet-Induced Dysregulation of Immune Cells Correlates with Macrophage Phenotypes and Chronic Inflammation in Adipose Tissue.高脂饮食诱导的免疫细胞失调与脂肪组织中巨噬细胞表型和慢性炎症相关。
Cells. 2022 Apr 13;11(8):1327. doi: 10.3390/cells11081327.
8
Short-term High Fructose Intake Reprograms the Transcriptional Clock Rhythm of the Murine Extraorbital Lacrimal Gland.短期高果糖摄入可重塑小鼠眼外泪腺转录钟节律。
Invest Ophthalmol Vis Sci. 2019 May 1;60(6):2038-2048. doi: 10.1167/iovs.18-26030.
9
High-Fat Diet-Induced Functional and Pathologic Changes in Lacrimal Gland.高脂肪饮食诱导的泪腺功能和病理变化。
Am J Pathol. 2020 Dec;190(12):2387-2402. doi: 10.1016/j.ajpath.2020.09.002. Epub 2020 Sep 11.
10
High Fat Diet Upregulates Fatty Acid Oxidation and Ketogenesis via Intervention of PPAR-γ.高脂饮食通过干预PPAR-γ上调脂肪酸氧化和生酮作用。
Cell Physiol Biochem. 2018;48(3):1317-1331. doi: 10.1159/000492091. Epub 2018 Jul 26.

引用本文的文献

1
The Complex Roles of Macrophages in Sjögren's Syndrome: A Narrative Review.巨噬细胞在干燥综合征中的复杂作用:一篇叙述性综述
Cureus. 2025 Aug 6;17(8):e89486. doi: 10.7759/cureus.89486. eCollection 2025 Aug.
2
Plin2 Coordinates Immune and Metabolic Reprogramming in Lacrimal Gland Aging.Plin2协调泪腺衰老过程中的免疫和代谢重编程。
Invest Ophthalmol Vis Sci. 2025 Jun 2;66(6):79. doi: 10.1167/iovs.66.6.79.